MediciNova Stock (NASDAQ: MNOV) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 25.000 / 60.512K |
Day Range | - - - |
52 Wk Range | 1.260 - 2.660 |
Market Cap | $72.088M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 59 |
Short Interest | 0.61% |
Days to Cover | 6.04 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of MediciNova (NASDAQ: MNOV) through any online brokerage.
Other companies in MediciNova’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Kezar Life Sciences (NASDAQ:KZR), Gain Therapeutics (NASDAQ:GANX), Intensity Therapeutics (NASDAQ:INTS) and Curis (NASDAQ:CRIS).
The latest price target for MediciNova (NASDAQ: MNOV) was reported by Maxim Group on Wednesday, March 10, 2021. The analyst firm set a price target for 15.00 expecting MNOV to rise to within 12 months (a possible 920.55% upside). 0 analyst firms have reported ratings in the last year.
The stock price for MediciNova (NASDAQ: MNOV) is $1.4698 last updated March 27, 2024 at 5:46 PM EDT.
There are no upcoming dividends for MediciNova.
MediciNova’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for MediciNova.
MediciNova is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.